Tests performed by the Department of Alternative Toxicological Methods
Head: Kristina Kejlová, M.Sc., Ph.D.
- cytotoxicity testing (test on extract, material, direct contact)
ISO 10993-5 Biological evaluation of medical devices – Part 5: Tests for cytotoxicity: in vitro methods.
- phototoxicity testing – 3T3 Balb/c Neutral Red Uptake Photoxicity Test
Commission Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Method B.41)
OECD TG 432: In Vitro 3T3 NRU Phototoxicity Test (2004)
- cytotoxicity assay for acute oral toxicity testing – 3T3 Balb/c Neutral Red Uptake Test
OECD Guidance Document No 129 on using Cytotoxicity Tests to Estimate Starting Doses for Acute Oral Systemic Toxicity Tests (2010)
- phototoxicity testing – 3D skin model EpiDermTM
OECD TG 498: In Vitro Phototoxicity – Reconstructed Human Epidermis Phototoxicity Test Method (2021)
- skin corrosion testing – 3D skin model EpiDermTM
COMMISSION REGULATION (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Method B.40a)
OECD TG 431: In Vitro Skin Corrosion: Human Skin Model Test (2019)
- skin irritation testing – 3D skin model EpiDermTM
Commission Regulation (EC) No. 761/2009 of 23 July 2009 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Method B.46)
OECD TG 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method (2021)
ISO 10993-23 Biological evaluation of medical devices – Part 23: Tests for irritation (2021)
- eye irritation testing – 3D model EpiOcularTM
OECD TG 492: Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage (2019)
- eye irritation testing – Hen´s Egg Test on the Chorioallantoic Mebrane (HET-CAM)
DB-ALM Protocol n° 47: HET-CAM Test
https://jeodpp.jrc.ec.europa.eu/ftp/jrc-opendata/EURL-ECVAM/datasets/DBALM/LATEST/online/dbalm.html
- genotoxicity testing of chemicals – in vitro chromosome aberration test
- cytogenetic analysis of human lymphocytes of subjects professionally exposed to genotoxic agent
Commission Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Method B.10)
OECD TG 473: In Vitro Mammalian Chromosomal Aberation Test (2016)
- mutagenicity testing of chemicals – reverse mutation test using bacteria (Ames Test)
Commission Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Method B.13/14)
OECD TG 471: Bacterial Reverse Mutation Test (2020)
- sensitization – in chemico Direct Peptide Reactivity Assay – DPRA
OECD TG 442C: In Chemico Skin Sensitisation – Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins (2022)
- sensitization – in vitro test LuSens
OECD TG 442D: In Vitro Skin Sensitisation – ARE-Nrf2 Luciferase Test Method (2022)
- sensitization – in vitro test HCLAT
OECD TG. 442E: In Vitro Skin Sensitisation – In Vitro Skin Sensitisation assays addressing
the Key Event on activation of dendritic cells on the Adverse Outcome Pathway for Skin
Sensitisation
- skin absorption in vitro
OECD TG 428: Skin Absorption: In Vitro Method (2004)
- test for estrogenic and androgenic agonistic/antagonistic activity (potential of endocrine disruption)
Yeast based reporter gene assay (Xenoscreen® YES/YAS, Xenometrix, Switzerland)